NCT03921866 - UK Ibrance Patient Program (IPP) Study | Biotech Hunter

Enrollment

191

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

March 4, 2021

Study Completion Date

March 4, 2021

Conditions

HR+/HER2- Locally Advanced, Metastatic Breast Cancer

Interventions

DRUG

Palbociclib

Trial Locations (8)

Royal Cornwall Hospital, Truro

Brighton Sussex Cancer Centre, Brighton

Beatson West of Scotland Cancer Centre, Glasgow

Guys and St Thomas' NHS Trust, London

Maidstone Hospital, Maidstone

The Christie NHS Foundation Trust, Manchester

Clatterbridge, Metropolitan Borough of Wirral

Newcastle Freeman Hospital, Newcastle upon Tyne